AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: Phosphagenics $19.3 million Capital raising, page-42

  1. 5,322 Posts.
    Sarto. POH does not see the results of its Acne Trial until datalock. As the results are material they must be ann to the market straight away. To suggest that POH has these results, is dissapointed with them, and is sitting in them would put them in breach of ASIC rules.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.